Myelotoxicity and hepatotoxicity during azathioprine therapy

Netherlands Journal of Medicine

Volumn 63, Issue 11, 2005, Pages 444-446

  de Boer, N K H ^a   Mulder, C J J ^a   van Bodegraven, A A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

6 thioguaninenucleotides; Azathioprine; Crohn's disease; Hepatotoxicity; Liver cirrhosis; Myelotoxicity

Indexed keywords

AZATHIOPRINE; PROPRANOLOL; THIOGUANOSINE; THIOPURINE METHYLTRANSFERASE;

ABDOMINAL RADIOGRAPHY; ADULT; ALLELE; AMINO ACID BLOOD LEVEL; ARTICLE; BONE MARROW TOXICITY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; CROHN DISEASE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ECHOGRAPHY; ERYTHROCYTE COUNT; ESOPHAGUS VARICES; GASTROINTESTINAL ENDOSCOPY; GENETIC ANALYSIS; GENOTYPE; HEPATOGRAPHY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FUNCTION TEST; LIVER TOXICITY; LYMPHOCYTE COUNT; MALE; PATIENT MONITORING; PORTAL HYPERTENSION; RISK ASSESSMENT; THROMBOCYTE COUNT;

ADULT; AZATHIOPRINE; BIOPSY; BLOOD PLATELETS; BONE MARROW; CROHN DISEASE; GUANINE NUCLEOTIDES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTES; LIVER; LIVER CIRRHOSIS; MALE; THIONUCLEOTIDES;

EID: 29644437766     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med 1995;123:132-42.
2. Candy S, Wright J, Gerber M, Adams G, Gerig M, Goodman R. A controlled double blind study of azathioprine in the management of Crohn's disease. Gut 1995;37:674-8.
3. Fonseca V, Havard CW. Portal hypertension secondary to azathioprine in myasthenia gravis. Postgrad Med J 1988;64:950-2.
4. Haboubi NY, Ali HH, Whitwell HL, Ackrill P. Role of endothelial cell injury in the spectrum of azathioprine-induced liver disease after renal transplant: light microscopy and ultrastructural observations. Am J Gastroenterol 1988;83:256-61.
5. Daniel F, Cadranel J, Seksik P, et al. Azathioprine induced nodular regenerative hyperplasia in IBD patients. UEGW 2004; A221.
6. Russmann S, Zimmermann A, Krahenbuhl S, Kern B, Reichen J. Venoocclusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis. Eur J Gastroenterol Hepatol 2001;13:287-90.
7. Sterneck M, Wiesner R, Ascher N, et al. Azathioprine hepatotoxicity after liver transplantation. Hepatology 1991;14:806-10.
8. Holtmann M, Schreiner O, Kohler H, et al. Veno-occlusive disease (VOD) in Crohn's disease (CD) treated with azathioprine. Dig Dis SCi 2003;48:1503-5.
9. Dubinsky MC, Lamothe S, Yang HY, et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 2000;118:705-13.
10. Tiede I, Fritz G, Strand S, et al. CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. J Clin Invest 2003;111:1133-45.
11. Al Hadithy AF, de Boer NK, Derijks LJ, Escher JC, Mulder CJ, Brouwers JR. Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations. Dig Liver Dis 2005;37:282-97.
12. Lennard L, Singleton HJ. High-performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: quantitation of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sample. J Chromatogr 1992;583:83-90.
13. Schutz E, Gummert J, Mohr FW, Armstrong VW, Oellerich M. Azathioprine myelotoxicity related to elevated 6-thioguanine nucleotides in heart transplantation. Transplant Proc 1995;27:1298-1300.
14. Lowry PW, Franklin CL, Weaver AL, et al. Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease. Gut 2001;49:665-70.
15. Lennard L. TPMT in the treatment of Crohn's disease with azathioprine. Gut 2002;51:143-6.
16. Dubinsky MC, Vasiliauskas EA, Singh H, et al. 6-thioguanine can cause serious liver injury in inflammatory bowel disease patients. Gastroenterology 2003;125:298-303.
17. DeLeve LD, Wang X, Kuhlenkamp JF, Kaplowitz N. Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease. Hepatology 1996;23:589-99.